Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
May 13 LDOS Zacks.com featured highlights Hasbro, Brinker International, DaVita, Leidos Holdings and Allstate
May 11 AXSM Prediction: These 2 Growth Stocks Could Triple By 2030
May 10 MACK Merrimack Pharmaceuticals stockholders approve plan of dissolution
May 10 NKTR Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript
May 10 MACK Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
May 10 VNDA Vanda Pharmaceuticals Reports Mixed Q1 2024 Results, Misses Revenue Estimates
May 10 NKTR Nektar Therapeutics (NKTR) First Quarter 2024 Earnings Overview
May 10 NKTR Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
May 10 NKTR Q1 2024 Nektar Therapeutics Earnings Call
May 10 DCPH Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings
May 10 DCPH Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates
May 10 LDOS 5 Stocks Trading Near 52-Week High With More Upside Potential
May 10 FUSN Fusion Pharmaceuticals doses first subject in prostate cancer trial
May 10 AXSM Why Axsome Therapeutics Is A Promising Stock Pick In CNS Treatments
May 10 NKTR Nektar Therapeutics, Inc. (NKTR) Q1 2024 Earnings Call Transcript
May 9 SRPT HHS panel to vote in Nov. on DMD screening for newborns
May 9 NKTR Nektar Therapeutics GAAP EPS of -$0.19, revenue of $21.6M
May 9 NKTR Nektar Therapeutics Reports First Quarter 2024 Financial Results
May 9 FUSN Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer
May 9 MACK Merrimack Pharmaceuticals intends to declare $15.10 dividend
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags